MPP Strikes Deal For Long-Acting Injectable HIV Candidate

Monthly Subcutaneous Injection Licensed From University Of Washington Could Replace Daily Pills

 
• By Chloe Kent
  
HIV ribbon
MPP has added another HIV candidate to its portfolio • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products